Candriam SCA’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.1M | Sell |
|
|||||
|
2025
Q1 | $7.99M | Sell |
|
|||||
|
2024
Q4 | $25.5M | Sell |
|
|||||
|
2024
Q3 | $41.9M | Buy |
|
|||||
|
2024
Q2 | $57.2M | Buy |
|
|||||
|
2024
Q1 | $47.1M | Buy |
|
|||||
|
2023
Q4 | $36.1M | Sell |
|
|||||
|
2023
Q3 | $45.7M | Buy |
|
|||||
|
2023
Q2 | $42.5M | Sell |
|
|||||
|
2023
Q1 | $57.7M | Sell |
|
|||||
|
2022
Q4 | $75.5M | Buy |
|
|||||
|
2022
Q3 | $29.1M | Buy |
|
|||||
|
2022
Q2 | $19.4M | Buy |
|
|||||
|
2022
Q1 | $22.4M | Sell |
|
|||||
|
2021
Q4 | $43M | Sell |
|
|||||
|
2021
Q3 | $80.3M | Sell |
|
|||||
|
2021
Q2 | $72.1M | Sell |
|
|||||
|
2021
Q1 | $39.8M | Hold |
|
|||||
|
2020
Q4 | $41.4M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $18.6M | Buy |
|